Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491042 | PMC |
| http://dx.doi.org/10.4103/IJO.IJO_528_23 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Three vs 6 Cycles of Chemotherapy for High-Risk Retinoblastoma: A Randomized Clinical Trial.
JAMA
November 2024
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.
Article Synopsis
- Adjuvant therapy, specifically CEV chemotherapy, is crucial for treating high-risk unilateral retinoblastoma, but there hasn't been sufficient comparison between administering 3 vs. 6 cycles of this treatment.
- A randomized trial involving 187 patients aimed to determine if 3 cycles of CEV chemotherapy is as effective as 6 cycles in terms of disease-free survival after enucleation.
- The results showed that the 3-cycle regimen had comparable disease-free survival rates and was associated with fewer adverse events and lower costs, suggesting it could be a more efficient treatment option.
Polarization-Sensitive OCT Imaging of Scleral Abnormalities in Eyes With High Myopia and Dome-Shaped Macula.
JAMA Ophthalmol
April 2024
Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.
Importance: The relevance of visualizing scleral fiber orientation may offer insights into the pathogenesis of pathologic myopia, including dome-shaped maculopathy (DSM).
Objective: To investigate the orientation and density of scleral collagen fibers in highly myopic eyes with and without DSM by polarization-sensitive optical coherence tomography (PS-OCT).
Design, Setting, And Participants: This case series included patients with highly myopic eyes (defined as a refractive error ≥6 diopters or an axial length ≥26.
Long-Term Risk and Prediction of Progression in Primary Angle Closure Suspect.
JAMA Ophthalmol
March 2024
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
Article Synopsis
- * The study aimed to find predictors of progression to PAC over a 14-year period in participants with untreated PACS, using various baseline eye examinations.
- * Results showed 25% of PACS eyes progressed to PAC, with factors like higher intraocular pressure and shallower anterior chamber depths indicating a greater risk of progression.
Buckle, Vitrectomy, or Both for Retinal Detachments with Inferior Breaks.
Ophthalmol Retina
October 2023
St. Louis, Missouri. Electronic address:
Posterior scleritis following COVID-19 vaccination or infection simulating uveal melanoma in 8 consecutive patients.
Eye (Lond)
January 2024
Shields and Shields, MD, PC, Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.
Objectives: To determine clinical features and outcomes of posterior scleritis masquerading as uveal melanoma following vaccination against COVID-19 and/or COVID-19 infection.
Subjects/methods: All patients with posterior scleritis referred to our service to rule out intraocular tumour between February 2021 and June 2022, who previously had COVID-19 vaccination and/or infection (n = 8). A retrospective detailed review of patient charts and imaging was carried out.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!